- Home
- MBNKO vs KLTOW Comparison
MBNKO vs KLTOW Comparison
Compare MBNKO & KLTOW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
MBNKO
Medallion Bank Fixed-Rate Reset Non-Cumulative Perpetual Preferred Stock Series G par value $1.00 per share
Current Price
Company Overview
Basic Information| Metric | MBNKO | KLTOW |
|---|---|---|
| Founded | N/A | N/A |
| Country | United States | United States |
| Employees | 136 | 3 |
| Industry | Commercial Banks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | N/A |
| IPO Year | N/A | 2022 |
Fundamental Metrics
Financial Performance| Metric | MBNKO | KLTOW |
|---|---|---|
| Price | $25.02 | $0.11 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | N/A | N/A |
| Earning Date | N/A | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | N/A | N/A |
| 52 Week High | N/A | N/A |
Technical Indicators
Market Signals| Indicator | MBNKO | KLTOW |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 42.60 |
| Support Level | N/A | $0.10 |
| Resistance Level | N/A | $0.11 |
| Average True Range (ATR) | 0.00 | 0.02 |
| MACD | 0.00 | -0.00 |
| Stochastic Oscillator | 0.00 | 32.15 |
Price Performance
Historical ComparisonAbout MBNKO Medallion Bank Fixed-Rate Reset Non-Cumulative Perpetual Preferred Stock Series G par value $1.00 per share
Medallion Bank is engaged in providing consumer loans, raising deposits, and managing other banking activities. It offers affordable financing for home improvement contractors, including window, siding, and roof replacements; kitchen, bath, and basement remodels; HVAC (Heating Ventilation and Air Conditioning), and solar PV installations. Medallion also offers recreation financing for new and used motorhomes, towable RVs, truck campers, cargo trailers, utility trailers, horse trailers, and a variety of ATVs and other power sport vehicles. Its segments are Recreation, Home Improvement, and Other. The company generates maximum revenue from the Recreation segment.
About KLTOW Klotho Neurosciences Inc. Warrant
Klotho Neurosciences Inc is in the development of essential medicines for the treatment of chronic diseases: Cancer, Cardiovascular, and Neurodegenerative disorders. The Company currently has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and a proprietary, patented gene therapy platform which uses a gene therapy approach to introduce a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases. Company pipeline includes KLTO 101, KLTO 202, KLTO 301.